◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY
Home › All stocks › CRNX › EPS

Crinetics Pharmaceuticals Inc (CRNX) EPS 2016–TTM

DATA UPDATED 2026-09-19

Crinetics Pharmaceuticals Inc annual earnings per share (EPS) for fiscal TTM was $-5.06, a decrease of 2.2% from $-4.95 in fiscal 2025. All figures are reported results from public filings — no estimates or projections.

CRNX Annual EPS

EPS (annual)TTM → 2026-06-302025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Earnings Per Share (EPS)$-5.06$-4.95$-3.69$-3.69$-3.08$-2.78$-2.39$-2.05$-2.23$-0.66$-0.43

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

CRNX Quarterly EPS

EPS (quarterly)2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-30
Earnings Per Share (EPS)$-1.14$-1.23$-1.31$-1.38$-1.23$-1.04$-0.88$-0.96$-0.94

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

EPS at Comparable Companies

More CRNX metrics: Revenue · Gross Profit · Operating Income · Net Income · EBITDA · Free Cash Flow · Shares Outstanding

All CRNX financial statements → Interactive CRNX charts →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.